📖 Your Q2 Earnings Guide: Discover the Stocks ProPicks AI Highlights to Jump Post-EarningsRead more

Point72 Asset Management established new holdings in Fulcrum Therapeutics, Inc.

Published 10/02/2020, 06:15 PM
Updated 10/02/2020, 06:30 PM
© Reuters.  Point72 Asset Management established new holdings in Fulcrum Therapeutics, Inc.
ALXN
-
IMMU
-
PLCE
-
AEO
-
ANGI
-
MGNX
-
AUPH
-
OTIC
-
RVLV
-
BCYC
-
FULC
-

On the 18th of September, Point72 Asset Management purchased 1.4 million Fulcrum Therapeutics, Inc. (NASDAQ:FULC) shares for $12 million at an average price of $8.53 per share. Shares of Fulcrum Therapeutics, Inc. are down -8.09% since the transaction.

Point72 Asset Management's holding in Fulcrum Therapeutics, Inc. established a new holding of about 1.4 million shares with the purchase.

Point72 Asset Management first bought Fulcrum Therapeutics, Inc. stock in the second quarter of 2020. Point72 Asset Management also owns Alexion Pharmaceuticals Inc (NASDAQ:ALXN), Immunomedics Inc (NASDAQ:IMMU), Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) and Arena Pharmaceuticals, Inc. (ARNA). Fulcrum Therapeutics, Inc. is its number sixteen position by number of shares and market value among pharmaceuticals stocks.

Contrary to Point72 Asset Management, Millennium Management reduced FULC shares, while Victory Capital Management and Squarepoint Ops sold all their FULC shares.

Point72 Asset Management has also recently added to their share in Otonomy, Inc. (NASDAQ:OTIC). The total value of the shares bought is estimated at around $8.9 million.

Point72 Asset Management also established new holdings in ANGI Homeservices Inc. (NASDAQ:ANGI) and Dave & Busters Entertainment Inc (PLAY). Point72 Asset Management also added to their share in American Eagle Outfitters Inc (NYSE:AEO), The Children's Place, Inc. (NASDAQ:PLCE), MacroGenics, Inc. (NASDAQ:MGNX), Bicycle Therapeutics plc (NASDAQ:BCYC) and Revolve Group , Inc. (NYSE:RVLV). The total value of the shares bought is estimated at around $313 million.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.